Isabel Sanchez-Romero
Overview
Explore the profile of Isabel Sanchez-Romero including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
270
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Penalva G, Canton R, Perez-Rodriguez M, Gonzalez-Lopez J, Rodriguez-Bano J, Barrio-Tofino E, et al.
Lancet Reg Health Eur
. 2025 Feb;
51:101220.
PMID: 39958398
Background: Assessing the burden of antimicrobial resistance is essential to determine the magnitude of this problem and to set its priority. We aimed to estimate the burden of disease caused...
2.
Monzo-Gallo P, Lopera C, Badia-Tejero A, Machado M, Garcia-Rodriguez J, Vidal-Cortes P, et al.
Int J Infect Dis
. 2024 Jul;
146:107188.
PMID: 39067149
No abstract available.
3.
Dahdouh E, Gomez-Marcos L, Canada-Garcia J, de Arellano E, Sanchez-Garcia A, Sanchez-Romero I, et al.
Front Cell Infect Microbiol
. 2024 May;
14:1390966.
PMID: 38817448
Introduction: Carbapenemase-Producing (CP-Eco) isolates, though less prevalent than other CP-Enterobacterales, have the capacity to rapidly disseminate antibiotic resistance genes (ARGs) and cause serious difficult-to-treat infections. The aim of this study...
4.
Monzo-Gallo P, Lopera C, Badia-Tejero A, Machado M, Garcia-Rodriguez J, Vidal-Cortes P, et al.
Int J Infect Dis
. 2024 Apr;
144:107070.
PMID: 38663477
Objectives: Information is scarce on clinical experiences with non-neutropenic patients with invasive fungal infection (IFI) receiving isavuconazole. We aimed to report the safety and effectiveness of this drug as a...
5.
Puerta-Alcalde P, Monzo-Gallo P, Aguilar-Guisado M, Ramos J, Laporte-Amargos J, Machado M, et al.
J Infect
. 2023 May;
87(1):46-53.
PMID: 37201859
Objectives: We describe the current epidemiology, causes, and outcomes of breakthrough invasive fungal infections (BtIFI) in patients with haematologic malignancies. Methods: BtIFI in patients with ≥ 7 days of prior...
6.
Diego-Yague I, Mora-Vargas A, Vazquez-Comendador J, Santamarina-Alcantud B, Fernandez-Cruz A, Munez-Rubio E, et al.
Clin Microbiol Infect
. 2023 Feb;
29(6):744-750.
PMID: 36773773
Objectives: We aimed to analyse the efficacy and safety of oral sequential therapy (OST) in uncomplicated Staphylococcus aureus bacteraemia (SAB). Methods: Single-centre observational cohort at a tertiary hospital in Spain,...
7.
Trevijano-Contador N, Torres-Cano A, Carballo-Gonzalez C, Puig-Asensio M, Martin-Gomez M, Jimenez-Martinez E, et al.
Open Forum Infect Dis
. 2022 Dec;
9(11):ofac605.
PMID: 36467290
Background: is a frequent cause of candidemia worldwide. Its incidence is associated with the use of medical implants, such as central venous catheters or parenteral nutrition. This species has reduced...
8.
Diaz-Garcia J, Gomez A, Alcala L, Reigadas E, Sanchez-Carrillo C, Perez-Ayala A, et al.
Antimicrob Agents Chemother
. 2022 Jul;
66(8):e0071022.
PMID: 35852369
We have been monitoring the antifungal resistance in Candida parapsilosis isolates collected from inpatients at Madrid metropolitan area hospitals for the last 3 years. The study aimed to elucidate the...
9.
Ramos-Martinez A, Pintos-Pascual I, Guinea J, Gutierrez-Villanueva A, Gutierrez-Abreu E, Diaz-Garcia J, et al.
J Fungi (Basel)
. 2022 May;
8(5).
PMID: 35628707
Severely ill COVID-19 patients are at high risk of nosocomial infections. The aim of the study was to describe the characteristics of candidemia during the pre-pandemic period (January 2019−February 2020)...
10.
Calderon-Parra J, Diego-Yague I, Santamarina-Alcantud B, Mingo-Santos S, Mora-Vargas A, Vazquez-Comendador J, et al.
J Clin Med
. 2022 Mar;
11(6).
PMID: 35329827
Background: It is unclear whether the use of clinical prediction rules is sufficient to rule out infective endocarditis (IE) in patients with bacteremia (SAB) without an echocardiogram evaluation, either transthoracic...